Sun Pharma posted a net profit of INR 1,985 crore ($266m) in Q4 FY23 due to increased specialty drug sales and strong growth in domestic formulations and emerging markets. The firm made a net loss of INR 2,277 crore in the same quarter of the previous year. T…